Drug profile · INN
ammonia n-13
AMMONIA N 13
ammonia n-13 (AMMONIA N 13) is a diagnostic agent. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — ammonia n-13
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 20
- Programs
- 0
- Data quality
- 0.89
Quick answer
ammonia n-13 (AMMONIA N 13) is a diagnostic agent. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related patents
-
US 12233135
Therapeutic constructs for treating cancer
granted -
US 12162920
Hinge area and use of same in constructing car skeleton
granted -
US 12054501
Compositions and methods for inhibiting arginase activity
granted -
US 11931453
Drug delivery device
granted -
US 11866747
Engineered meganucleases that target human mitochondrial genomes
granted -
US 11826392
Purification method of fungal cell wall composition
granted -
US 11490643
Lactobacillus casei for treating obesity and associated metabolic disorders
granted -
US 11317888
Non-invasive method for pressure measurement
granted -
US 11191935
Implant delivery system with hydration promotor capability
granted -
US 11129791
Drug delivery device
granted -
US 11078245
Colon and pancreas cancer peptidomimetics
granted -
US 10792481
Implantable drug delivery device
granted -
US 10662440
Self-limiting viral vectors encoding nucleases
granted -
US 10653169
Food thickening agent, method for producing food thickening agent
granted -
US 10533040
Colon and pancreas cancer peptidomimetics
granted -
US 10525248
Apparatus and method for promoting fluid uptake into an implant
granted -
US 10327461
Food thickening agent, method for producing food thickening agent
granted -
US 10214721
Method for making culture medium
granted -
US 10105523
Implantable drug delivery device
granted -
US 10006052
Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof
granted
Frequently asked questions
What is ammonia n-13?
ammonia n-13 (AMMONIA N 13) is a diagnostic agent. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for ammonia n-13?
AMMONIA N 13 is a marketed brand name for ammonia n-13. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ammonia n-13?
ammonia n-13 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.